- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Eden Prairie Today
By the People, for the People
Sanuwave Health Reports Q1 2026 Revenue Increase
Medical device company sees 3-4% year-over-year growth in preliminary Q1 results.
Apr. 16, 2026 at 11:01pm
Got story updates? Submit your updates here. ›
Sanuwave's Q1 revenue growth signals continued demand for its innovative medical devices.Eden Prairie TodaySanuwave Health, a medical device company, has reported preliminary revenue of $9.6 million to $9.7 million for the first quarter of 2026, representing a 3-4% increase compared to the same period in the previous year. The company's results are in line with its prior guidance for Q1.
Why it matters
Sanuwave's Q1 revenue growth indicates the company's products and services continue to see demand, which is an important signal for its overall financial health and ability to invest in future product development and market expansion.
The details
Sanuwave Health, a medical device company focused on wound care and regenerative medicine, announced its preliminary financial results for the first quarter of 2026. The company reported revenue in the range of $9.6 million to $9.7 million, up 3-4% compared to the first quarter of 2025.
- Sanuwave reported preliminary Q1 2026 results on April 16, 2026.
The players
Sanuwave Health Inc
A medical device company focused on wound care and regenerative medicine products and services.
The takeaway
Sanuwave's Q1 revenue growth demonstrates the continued demand for its medical devices and treatments, positioning the company for potential future investments and expansion in the wound care and regenerative medicine markets.

